In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lectus Therapeutics Ltd.

www.lectustherapeutics.com

Latest From Lectus Therapeutics Ltd.

Redx appoints new CSO and CFO

UK-based Redx Pharma has promoted Dr Richard Armer to chief scientific officer and Phil Tottey to chief financial officer.

Fate tempts Takeda's interest in stem cell technology

Takeda has invested in the private US stem cell company Fate Therapeutics as part of a broader effort to get closer to novel drug discovery and regenerative medicine technology.

Cardiovascular Cancer

Market Insight - A fresh look at ion channels

Mark Greener reviews a selection of ion channels currently attracting researchers' attention, demonstrating renewed interest in the clinical and commercial potential of an underexploited therapeutic target

Gastrointestinal Metabolic Disorders

Lectus Therapeutics appoints new chairman

The chairman and CEO of Ablynx, Dr Edwin Moses, has been appointed non-executive chairman of the UK drug discovery and development company Lectus Therapeutics. Professor Raymond Hill, who was, until April 2008, executive director of licensing and external research (Europe) for Merck, Sharp & Dohme Research Laboratories, has been named non-executive director. Lectus has also appointed Dr Chas Bountra chairman of, and Professor Annette Dolphin to, its scientific advisory board (SAB). Mr Bountra succeeds Professor Leslie Iversen, who has chaired the SAB since its first meeting in 2003.

Companies
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Lectus Therapeutics Ltd.
  • Senior Management
  • Roland Kozlowski, PhD, CEO
    Richard Armer, PhD, Research Dir.
    Angus Hone, Dir., Fin.
  • Contact Info
  • Lectus Therapeutics Ltd.
    Phone: (44) 1223 496182
    Babraham Research Campus
    Cambridge, CB22 3AT
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register